Trump administration announces $2.8 billion bomb sale to Israel

The Trump administration has moved forward with a $2.8 billion foreign military sale to Israel that includes precision‑guided bombs and related equipment, despite mounting criticism from human‑rights organizations and foreign policy observers who argue the weapons could be used in operations that target civilian populations in the Gaza Strip.

State Department officials said the sale, which comprises thousands of Joint Direct Attack Munitions (JDAMs) and associated support kits, was reviewed under the standard inter‑agency process and deemed consistent with U.S. law and policy. The administration highlighted Israel’s right to self‑defence and the precision nature of the weapons as mitigating factors, while noting that the transaction had been reported to Congress as required. Advocacy groups such as Amnesty International and the United Nations Office for the Coordination of Humanitarian Affairs have condemned the deal, citing recent reports of high civilian casualties and calling for a pause on new arms transfers until an independent investigation into alleged war crimes is completed.

The approval of the sale proceeds amid a broader debate over U.S. arms exports to conflict zones, with lawmakers and NGOs urging greater scrutiny of the humanitarian impact. The administration maintains that the weapons will enhance Israel’s ability to conduct targeted strikes, but the controversy underscores ongoing tensions between strategic alliances and concerns over civilian protection in the region.